Chai Discovery Raises $400 Million for AI-Designed Medicines
The molecular design startup reached a $3.8 billion valuation while expanding partnerships with major drugmakers.
Archive
The molecular design startup reached a $3.8 billion valuation while expanding partnerships with major drugmakers.
